Clinical Trials Browser

Biochemically Recurrent Prostate Cancer × darolutamide × 30 days × Clear all

NCT05794906 2026-03-17

ARASTEP

Phase 3 Active not recruiting

Biochemically Recurrent Prostate Cancer

NCT05526248 2026-03-11

ARAMON

Phase 2 Completed

28 enrolled 14 charts

Biochemically Recurrent Prostate Cancer